tiprankstipranks
Trending News
More News >

CSPC Pharmaceutical Group Updates Nomination Committee Terms

Story Highlights
CSPC Pharmaceutical Group Updates Nomination Committee Terms

Don’t Miss TipRanks’ Half-Year Sale

CSPC Pharmaceutical Group ( (HK:1093) ) has issued an announcement.

CSPC Pharmaceutical Group Limited has updated the terms of reference for its Nomination Committee, which is responsible for reviewing the board’s structure and diversity, identifying and recommending director candidates, and assessing the independence of non-executive directors. This move aims to enhance the company’s governance and ensure alignment with its corporate strategy, potentially impacting its operational efficiency and stakeholder confidence.

The most recent analyst rating on (HK:1093) stock is a Buy with a HK$6.80 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.

More about CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. The company focuses on the development, manufacturing, and sale of pharmaceutical products, with a market emphasis on providing innovative healthcare solutions.

Average Trading Volume: 218,895,274

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$91.65B

For an in-depth examination of 1093 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1